Avonex and Appetite decreased - a phase IV clinical study of FDA data
Summary:
Appetite decreased is found among people who take Avonex, especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Avonex and have Appetite decreased. It is created by eHealthMe based on reports of 193,076 people who have side effects when taking Avonex from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
193,076 people reported to have side effects when taking Avonex.
Among them, 895 people (0.46%) have Appetite decreased.
What is Avonex?
Avonex has active ingredients of interferon beta 1a. It is often used in multiple sclerosis. eHealthMe is studying from 193,476 Avonex users for its effectiveness, alternative drugs and more.
What is Appetite decreased?
Appetite decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 4,281 drugs and 4,315 conditions by eHealthMe.
Number of Avonex and Appetite decreased reports submitted per year:
Time on Avonex when people have Appetite decreased *:
Gender of people who have Appetite decreased when taking Avonex*:
Age of people who have Appetite decreased when taking Avonex *:
Common drugs people take besides Avonex *:
Common side effects people have besides Appetite decreased *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Avonex and have Appetite decreased?
Check whether Appetite decreased is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Appetite decreased and when was it recovered:
Expand to all the drugs that have ingredients of interferon beta 1a:
Alternative drugs to, pros and cons of Avonex:
- Avonex (193,476 reports)
Common Avonex side effects:
- Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11,634 reports
- Fatigue (feeling of tiredness): 11,112 reports
- Weakness: 10,310 reports
- Memory loss: 9,871 reports
Browse all side effects of Avonex:
a b c d e f g h i j k l m n o p q r s t u v w x y zAppetite decreased treatments and more:
- Appetite decreased (223,291 reports)
COVID vaccines that are related to Appetite decreased:
- Appetite decreased in Moderna COVID Vaccine
- Appetite decreased in Pfizer BioNTech Covid Vaccine
- Appetite decreased in Johnson and Johnson Covid Vaccine
Common drugs associated with Appetite decreased:
- Aspirin: 11,299 reports
- Metformin: 10,636 reports
- Prednisone: 9,661 reports
- Omeprazole: 7,469 reports
- Amlodipine: 6,953 reports
- Humira: 6,804 reports
- Byetta: 6,471 reports
- Lisinopril: 6,201 reports
- Methotrexate: 5,770 reports
- Furosemide: 5,681 reports
All the drugs that are associated with Appetite decreased:
- Appetite decreased (4,281 drugs)
Common conditions associated with Appetite decreased:
- Type 2 diabetes: 10,766 reports
- High blood pressure: 10,483 reports
- Rheumatoid arthritis: 7,499 reports
- Pain: 7,126 reports
- Multiple myeloma: 6,537 reports
All the conditions that are associated with Appetite decreased:
- Appetite decreased (4,315 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on interferon beta 1a (the active ingredients of Avonex) and Avonex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tramadol and Spinal Pain - 3 seconds ago
- Glucophage and Bromocriptine Mesylate drug interaction - 5 seconds ago
- Prohance and Throat Oedema - 8 seconds ago
- Atenolol and Lymphocele - 21 seconds ago
- Invega and Pharyngeal Ulceration - 24 seconds ago
- Rilutek and Parlodel drug interaction - 36 seconds ago
- Duopa and Throat Irritation - 36 seconds ago
- Diethylstilbestrol and International Normalised Ratio Increased - 42 seconds ago
- Doxy-Sleep-Aid vs. Zyprexa - 42 seconds ago
- Lisinopril And Hydrochlorothiazide and Xolair drug interaction - 44 seconds ago